At the heart of supramolecular robotics lies the principle that molecules themselves can serve as dynamic building blocks, organizing and reorganizing in response to subtle chemical stimuli. This fluency in molecular choreography grants the materials an unprecedented degree of programmability, enabling them to execute complex motions and structural changes reminiscent of biological processes like motility and tissue formation. The research team, led by Associate Professor Taisuke Banno at Keio University, delineates a roadmap to engineering soft materials imbued with life-like functionalities without relying on rigid, predesigned architectures.

Motility—the capability for autonomous movement—emerges as a foundational attribute within this framework. Employing micron-sized oil droplets suspended in aqueous environments, the researchers exploited the Marangoni effect, whereby gradients in interfacial tension induce surface flows that propel droplets spontaneously. These chemically powered droplets can navigate their surroundings directionally or collectively organize into swarming patterns evocative of microbial colonies. This ability to translate microscale physicochemical gradients into purposeful locomotion represents a potent strategy for fabricating microscale soft robots with applications ranging from precision drug delivery to environmental sensing.

Complementing motility is the dynamic phenomenon of phase transitions, where supramolecular assemblies reversibly switch between distinct structural states such as micelles, vesicles, and gels. Triggered by external stimuli—including variations in pH or light exposure—these transformations are integral to achieving adaptive functionality within the materials. They parallel biological responses observed in natural systems, enabling materials to heal, remodel, or activate therapeutics in a controlled manner under nonequilibrium conditions. This responsive phase behavior anchors the materials’ versatility and adaptability in fluctuating environments.

The assembly of individual protocell-like vesicles into larger, tissue-like structures—termed prototissue formation—marks another remarkable achievement within supramolecular robotics. Guided by finely tuned non-covalent interactions, these protocells organize into coherent multicompartmental entities exhibiting collective behaviors and communication across boundaries. Through reversible interactions, these macroscopic structures can respond adaptively, mimicking cellular communication and repair mechanisms. Such self-organized prototissues herald a new paradigm in constructing soft materials that integrate emergent functionalities from the bottom up.

The research underlines the vital role of chemical signal processing in enabling these adaptive systems. By weaving molecular recognition with dynamic assembly and disassembly, the materials operate as autonomous entities capable of processing environmental information and executing coordinated responses. This integrated responsiveness sets supramolecular robotics apart from prior bioinspired materials that typically rely on isolated or static functionalities. The approach elevates soft materials from passive responders to active agents resembling living matter in complexity.

One of the most visually compelling demonstrations from the study showcases the ability to “write” with molecular assemblies by shaping vesicle-based prototissue fibers into letter-shaped patterns on the microscale. This molecular handwriting underscores the programmable and processable nature of these materials, opening prospects for microscopic patterning and encoding information through soft matter architectures. Such sophisticated control over material form and function posits intriguing possibilities for information storage, tissue engineering, and responsive surfaces.

Looking beyond the laboratory bench, the implications of supramolecular robotics are vast and transformative. In biomedicine, these adaptive soft materials could revolutionize targeted drug delivery by navigating complex biological milieus, releasing therapeutic payloads precisely in response to physiological cues. Environmental science stands to benefit from microscale autonomous systems capable of detecting and neutralizing pollutants with minimal external oversight. Additionally, in robotics, the incorporation of molecularly driven motion and self-regulation portends the creation of next-generation soft robots unbounded by rigid mechanical components.

The interdisciplinary collaboration vital to this advancement drew on the expertise of Dr. Tomoya Kojima and Ph.D. candidate Shoi Sasaki, reflecting the synthesis of chemistry, materials engineering, and systems design. Their focus on soft matter platforms like self-propelled droplets and coacervates highlights the diversity of molecular constructs harnessed within supramolecular robotics. This synergy between fundamental chemical interactions and emergent system-level behaviors defines the frontier of intelligent material research.

Central to these developments is the recognition that nonequilibrium and nonlinear phenomena govern the behavior of supramolecular systems, enabling them to sustain dynamic states far from thermodynamic equilibrium. This intrinsic energy dissipation and molecular flux mimic biological homeostasis and adaptability, underscoring the importance of supramolecular chemistry in constructing functional materials. Future research will likely deepen understanding of these principles to refine control over motion, assembly, and communication.

The researchers envision a future where molecular strategies foster autonomous materials that not only sense and respond but also evolve functionalities over time. Self-regulating soft materials could advance beyond predefined roles, adapting in unpredictable environments without external programming. This vision bridges the gap from molecular recognition to machine-like intelligence embedded in soft matter, challenging traditional paradigms in robotics and materials science.

Ultimately, the pioneering concept of supramolecular robotics redefines our relationship with materials—from static substrates to dynamic entities exhibiting life-like versatility. This emerging field may spark novel therapeutic modalities, environmental technologies, and robotic platforms that embody the fluid intelligence inherent in biological systems. As research progresses, the fusion of molecular chemistry with robotic principles promises to unlock a new era of adaptive, intelligent soft materials, pushing boundaries at the intersection of chemistry, biology, and engineering.

Subject of Research: Not applicable

Article Title: Toward Supramolecular Robotics: Molecular Strategies for Adaptive Soft Materials

News Publication Date: 7-Aug-2025

References: DOI: 10.1021/accountsmr.5c00070

Image Credits: Keio University, Japan

Keywords

Robotics, Applied sciences and engineering, Artificial intelligence, Supramolecular chemistry, Physical sciences

D-2HG is a metabolite of growing biomedical importance, recognized largely due to its role as an oncometabolite—an aberrant metabolite associated with cancer development and progression. Elevated levels of D-2HG have been linked to cancers such as gliomas and acute myeloid leukemia, in addition to certain metabolic disorders. Despite its significance, existing detection methods suffer from drawbacks including complexity, invasiveness, and limits in temporal resolution. Conventional techniques often rely on mass spectrometry or chromatography, which, while precise, necessitate laborious sample preparation and are confined to centralized laboratories. The advent of a genetically encoded biosensor circumvents many of these issues, facilitating bedside or even in situ metabolic analysis.

At the heart of this innovation lies a biosensor composed of a genetically encoded fluorescent protein fused to a D-2HG-binding domain. The design is elegantly tailored: upon binding D-2HG, conformational shifts induce quantifiable fluorescence changes, offering an instantaneous readout of metabolite concentration. This allosteric sensing mechanism allows for both quantitative and dynamic tracking, an essential feature when monitoring fluctuating metabolic landscapes within live cells. By employing fluorescence resonance energy transfer (FRET) or intensity-based fluorescence modulation, the biosensor converts molecular recognition events into optical signals, easily captured by standard microscopic and photometric devices.

Developing a sensor that distinguishes D-2HG from its chiral counterpart, L-2HG, posed a challenging biochemical conundrum. The research team harnessed the specificity of natural D-2HG-binding proteins, identified through extensive bioinformatic mining and structural modeling. Through iterative protein engineering and mutagenesis, they enhanced binding affinity and selectivity, ensuring minimal cross-reactivity. The final construct exhibits a remarkable ability to discern subtle concentration variations in complex biological milieus, an achievement critical to its utility in live-cell imaging and clinical diagnostics.

The functional validation of the biosensor involved rigorous testing in both cell lysates and living cells. In vitro assays demonstrated the capacity to detect D-2HG concentrations spanning physiologically and pathologically relevant ranges. Live-cell experiments revealed dynamic metabolic changes, enabling researchers to visualize D-2HG fluxes in response to genetic or pharmacological perturbations. This real-time insight into oncometabolite dynamics opens new avenues for understanding cancer metabolism and therapeutic responses, accelerating translational research efforts.

Moreover, the genetically encoded nature of the biosensor permits its introduction into various model systems via gene transfection, transduction, or stable genome integration. This versatility extends beyond human cells to microbial and animal models, where D-2HG-related metabolic pathways are conserved or implicated. Such adaptability enhances its scope in broad biomedical research contexts, ranging from developmental biology to drug screening platforms.

Of particular interest is the biosensor’s potential in point-of-care diagnostics. The portability and ease of fluorescence detection suggest a future where bedside metabolic monitoring could become a reality. This capability would empower clinicians with rapid, actionable insights into patient metabolic status, facilitating early diagnosis, real-time treatment monitoring, and personalized medicine approaches, especially in oncology where D-2HG serves as a biomarker for specific tumor types harboring isocitrate dehydrogenase (IDH) mutations.

In an era increasingly emphasizing precision medicine, tools that provide the temporal resolution of metabolic fluxes are invaluable. Traditional snapshot measurements of metabolites provide limited context about disease progression or treatment efficacy. This biosensor, by enabling continuous monitoring, captures the dynamic nature of metabolism and its nuanced interplay with cellular states. Such data richness promises refinement in disease modeling, therapeutic targeting, and our overarching understanding of metabolism’s role in health and disease.

Technologically, the engineering challenges surmounted in this research exemplify the power of interdisciplinary synthesis. Structural biology illuminated binding interfaces, synthetic biology principles guided sensor optimization, and optical physics underpinned signal transduction strategies. The seamless integration of these fields culminated in a functional biosensor with not only research but also clinical potential. The study’s comprehensive methodological approach serves as a template for the design of similar metabolite-specific sensors in the future.

Beyond cancer and metabolic disorders, D-2HG is implicated in broader physiological processes intersecting with epigenetics, redox biology, and mitochondrial function. Monitoring its fluctuations in live cells therefore touches upon fundamental biological questions. This biosensor could unveil previously inaccessible insights into how D-2HG orchestrates cellular signaling networks and contributes to pathophysiology. The translational implications range from uncovering novel drug targets to redefining biomarker paradigms in various diseases.

Importantly, the researchers addressed biosensor stability and biocompatibility, crucial factors for clinical uptake. Codon optimization, minimal cytotoxicity, and robust fluorescence output ensure that the sensor operates efficiently within cellular environments without perturbing native functions. These considerations mitigate common hurdles faced by genetically encoded sensors, such as photobleaching and interference with endogenous processes, thus reinforcing the sensor’s applicability in longitudinal studies.

The biosensor also holds promise in drug discovery and development pipelines. By enabling high-throughput screening of candidate compounds’ effects on D-2HG metabolism, it accelerates identification of effective inhibitors or modulators of pathological metabolic pathways. This application links molecular diagnostics with therapeutic innovation, exemplifying the sensor’s multifaceted utility.

Contextually, the importance of such a biosensor extends into emerging fields like synthetic biology and metabolic engineering. The capacity to monitor intracellular metabolite levels informs the design and optimization of engineered cells producing valuable metabolites or serving as biosynthetic factories. D-2HG detection becomes not only a diagnostic tool but a feedback element in synthetic circuits, enabling sophisticated metabolic control strategies.

The publication resonates beyond academic circles, heralding a paradigm shift in how metabolic biomarkers are detected and exploited clinically. Its viral potential stems from addressing urgent unmet needs in biomedical diagnostics with a tool that is elegant, efficient, and scalable. As metabolic reprogramming is recognized as a hallmark of various diseases, the demand for such precise, dynamic detection platforms will inevitably rise, positioning this genetically encoded biosensor at the forefront of future biomedical innovations.

In summary, the deployment of this genetically encoded D-2HG biosensor marks a pivotal step in merging biosensing technology with metabolic disease management. It bridges fundamental research with clinical application, offering a versatile, robust, and sensitive approach to monitor an oncometabolite intricately linked to human health. This advancement underscores the transformative power of interdisciplinary science, promising to reshape diagnostics, therapeutics, and biochemical understanding alike in the near future.

Subject of Research: Genetically encoded biosensor development for detecting D-2-hydroxyglutarate in point-of-care and live-cell contexts.

Article Title: A genetically encoded biosensor for point-of-care and live-cell detection of D-2-hydroxyglutarate.

Article References:
Liu, Y., Kang, Z., Xu, R. et al. A genetically encoded biosensor for point-of-care and live-cell detection of D-2-hydroxyglutarate. Nat Commun 16, 6913 (2025). https://doi.org/10.1038/s41467-025-62225-8

Image Credits: AI Generated

Molecular nanocarbons, minuscule carbon-based architectures with extraordinary mechanical strength, electrical conductivity, and luminescent properties, are pivotal to cutting-edge technological applications. These include aerospace engineering, where lightweight yet robust materials are essential; next-generation battery systems demanding efficient electron transport; and the ever-evolving realm of electronics, relying on precise molecular constructs for miniaturization and performance improvements. Despite their immense potential, fabricating molecular nanocarbons with exact atomic precision and altering their defined geometries has persistently vexed chemists. The delicacy of their defined shape renders conventional synthetic processes prone to compromising molecular integrity.

Intriguingly, Itami’s team drew inspiration from biological systems, conjuring the provocative hypothesis of harnessing insects—famed for their metabolic versatility—as biological catalysts. Plant-feeding insects like caterpillars and grasshoppers naturally degrade complex and toxic phytochemicals through an arsenal of enzymatic pathways in their gut. These enzymatic transformations often involve oxidations and other modifications that can be challenging to replicate synthetically. Recognizing this remarkable biochemical adaptability, the researchers envisioned employing insects as living microreactors capable of performing intricate chemical reactions on molecular nanocarbons.

To test this innovative concept, the research team administered a specially designed molecular nanocarbon compound, named [6]MCPP, to tobacco cutworm caterpillars (Spodoptera litura), notorious for their rapid lifecycle and metabolic prowess. This belt-shaped nanocarbon was chosen for its structural intricacies and amenability to biological interactions. Remarkably, after just two days of feeding, chemical analyses revealed the formation of a novel oxygen-incorporated derivative, [6]MCPP-oxylene, within the caterpillars’ excreta. This subtle oxidation event endowed the originally inert molecule with fluorescence, marking a significant functional transformation.

The elucidation of the molecular structure of [6]MCPP-oxylene relied on sophisticated analytical platforms, including mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography. These complementary techniques unraveled the precise oxygen insertion site and confirmed the structural integrity of the nanocarbon framework post-modification. The pivotal biological agents orchestrating this rare transformation were identified as two cytochrome P450 enzymes, CYP X2 and CYP X3. Genetic analyses affirmed that disabling these enzymes abrogated the oxidative modification, underscoring their essential catalytic role.

Delving deeper into the mechanistic underpinnings, computer simulations and molecular docking studies revealed a highly unusual enzymatic interaction. These P450 enzymes were capable of simultaneously binding two [6]MCPP molecules and inserting an oxygen atom directly into a carbon–carbon bond—a chemically formidable feat rarely observed in biological systems. This enzymatic oxidation contrasts starkly with synthetic laboratory attempts, which either failed to induce the reaction or yielded only negligible amounts of the oxidized product, highlighting the unique catalytic environment within the insect gut.

This pioneering work heralds a paradigm shift in materials chemistry by integrating biological complexity into molecular manufacturing. Traditional chemistry relies heavily on controlled reactions in isolated glassware, often struggling with demanding manipulations on nanocarbon scaffolds. Conversely, the in-insect synthesis approach leverages evolved enzymatic machinery and biological environments to facilitate reactions that are otherwise chemically inaccessible. The biological context provides not only reaction specificity but also operational conditions—such as mild temperatures and aqueous media—that enhance molecular survival and functionalization.

Looking forward, the potential of this approach could be vastly expanded by coupling with modern biotechnology tools such as genome editing and directed evolution. Tailoring insect enzymes to catalyze an even broader spectrum of molecular modifications could enable the bespoke fabrication of molecular architectures with tailored electronic, optical, or mechanical functionalities. This fusion of organic chemistry with synthetic biology foreshadows a new era where living organisms become partners in molecular innovation, potentially giving rise to eco-friendly, sustainable production pathways that bypass energy-intensive industrial syntheses.

The tobacco cutworm, historically maligned as a resilient agricultural pest, assumes an unexpected heroic role in this study. Known for its prolific metabolism that confers pesticide resistance, this species demonstrates an inherent biochemical versatility that can be harnessed beneficially. The researchers reflect on this transformation from adversaries to enablers of advanced molecular synthesis as emblematic of the untapped potential residing in nature’s vast diversity.

Beyond molecular nanocarbon synthesis, this novel method prompts reconsideration of how complex organic molecules can be constructed and functionalized within living systems. The gut microbiome, enzyme diversity, and metabolic pathways of insects represent a treasure trove of catalytic possibilities, many of which remain largely unexplored by chemists. This approach challenges preconceived limits and illustrates the power of cross-disciplinary innovation—marrying entomology, enzymology, and nanomaterials science toward practical applications.

The ability to produce fluorescent nanocarbons through mild, bio-catalyzed oxidation could also inspire next-generation sensors, imaging agents, and optoelectronic devices. The molecular modifications achieved harness nature’s own selectivity and efficiency while overcoming the synthetic bottlenecks that have historically hampered scalability and functional tailoring. Moreover, in-insect synthesis might emerge as a platform technology, adaptable to other molecular targets beyond nanocarbons, potentially including pharmaceuticals, agrochemicals, and specialty materials.

In sum, the efforts by Itami and colleagues represent a visionary leap in chemical science. By transforming insects into living molecular foundries, the researchers circumvent entrenched challenges of synthetic chemistry, opening a pathway that reconciles molecular precision with biological complexity. The implications of in-insect synthesis reach far beyond isolated molecules, pointing to a future where biology and chemistry coalesce seamlessly to innovate sustainably and expansively.

Subject of Research: Animals
Article Title: In-insect synthesis of oxygen-doped molecular nanocarbons
News Publication Date: 5-Jun-2025
Web References: DOI: 10.1126/science.adp9384
References: Science, 2025, Itami et al. "In-insect synthesis of oxygen-doped molecular nanocarbons"
Image Credits: RIKEN

Keywords

Organic chemistry, Organic synthesis, Enzymes